Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study
Diabetes & Metabolism Journal · 2025
DOI: 10.4093/dmj.2024.0406 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes & Metabolism Journal, 2025. Verfasst von Eun Roh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hallym University Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Kidney Failure, Chronic, Cholesterol, Diabetic Nephropathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hallym University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Remnant cholesterol (remnant-C) has been linked to the risk of various vascular diseases, but the association between remnant-C and end-stage renal disease (ESRD) in patients with type 2 diabetes mellitus (T2DM) remains unclear.
Methods
Using a nationwide cohort, a total of 2,537,149 patients with T2DM without ESRD, who had participated in the national health screening in 2009, were enrolled and followed up until 2020. Low-density lipoprotein cholesterol (LDL-C) levels were assessed by the Martin-Hopkins method, and remnant-C was calculated as total cholesterol–LDL-C–high-density lipoprotein cholesterol.
Results
During a median follow-up period of 10.3 years, 26,246 patients with T2DM (1.03%) developed ESRD. Participants in the upper quartile of remnant-C had a higher risk of ESRD, with hazard ratios of 1.12 (95% confidence interval [CI], 1.08 to 1.17), 1.20 (95% CI, 1.15 to 1.24), and 1.33 (95% CI, 1.26 to 1.41) in the second, third, and fourth quartile, compared with the lowest quartile, in multivariable-adjusted analyses. The positive association between remnant-C and ESRD remained consistent, irrespective of age, sex, presence of pre-existing comorbidities, and use of anti-dyslipidemic medications. The increased risk of ESRD was more pronounced in high-risk subgroups, including those with hypertension, chronic kidney disease, obesity, and a longer duration of diabetes.
Conclusion
These findings suggest that remnant-C profiles in T2DM have a predictive role for future progression of ESRD, independent of traditional risk factors for renal dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Hallym University Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, Korea.
- Department of Statistics and Actuarial Science, College of Natural Sciences, Soongsil University, Seoul, Korea.
Förderung
- Hallym University
Zitieren
APA
Roh, E., Heo, J. H., Jung, H. N., Han, K. D., Kang, J. G., Lee, S. J., & Ihm, S. H. (2025). Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2024.0406
Vancouver
Roh E, Heo JH, Jung HN, Han KD, Kang JG, Lee SJ, et al. Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study. Diabetes & Metabolism Journal. 2025. doi:10.4093/dmj.2024.0406
BibTeX
@article{Roh2025,
author = {Roh, Eun and Heo, Ji Hye and Jung, Han Na and Han, Kyung-Do and Kang, Jun Goo and Lee, Seong Jin and Ihm, Sung-Hee},
title = {Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study},
journal = {Diabetes & Metabolism Journal},
year = {2025},
doi = {10.4093/dmj.2024.0406}
}
EUVIMED